Reversible sorafenib-associated coagulopathy identified by viscoelastic testing in a dog with intranasal sarcoma. [PDF]
Kim D, Jo Y, Kim S, Choi M, Kim Y.
europepmc +1 more source
Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer. [PDF]
Kampel L +15 more
europepmc +1 more source
Comparative Analysis of Septin Modifiers, Forchlorfenuron and UR214-9, on Mitochondrial Fragmentation and Lytic Cell Death. [PDF]
Brokatzky D +4 more
europepmc +1 more source
Successful treatment of β-catenin-positive, immune checkpoint inhibitor-resistant tumor in a case of multicentric hepatocellular carcinoma. [PDF]
Nomiya H +9 more
europepmc +1 more source
Efficacy of hydrocolloid dressing for hand-foot skin reaction: J-SUPPORT 1701 APRON trial. [PDF]
Ryu A +13 more
europepmc +1 more source
Long Term Disease Control of Brain Metastases From Chemotherapy-Resistant Endometrial Cancer With Lenvatinib and Pembrolizumab: A Case Report. [PDF]
Fujioka A +5 more
europepmc +1 more source
Overlapping Toxicities of Pembrolizumab and Lenvatinib: A Case of Capillary Leak Syndrome with Severe Erythroblastosis. [PDF]
Gkoufa A +6 more
europepmc +1 more source
Next-Generation Sequencing in Differentiated Thyroid Cancer Patients Treated with Lenvatinib: Results and Challenges in Real-Life Practice. [PDF]
Ferrari M +6 more
europepmc +1 more source
Lenvatinib-Induced Acalculous Cholecystitis-An Often-Unrecognized Toxicity: A Case Series and Literature Review. [PDF]
Cortas C, Symeonidou C, Charalambous H.
europepmc +1 more source
Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach. [PDF]
Nakhleh A +5 more
europepmc +1 more source

